Blood News and Research

RSS

Study reports uneven decline of colorectal cancer mortality rate

Black patients die from colorectal cancer at much higher rates than whites do and new research points to unequal health care as the cause. While deaths from colorectal cancer have declined over the past 40 years, the declines have been uneven, said lead author Samir Soneji, Ph.D., of the Robert Wood Johnson Health and Society Scholars Program at the University of Pennsylvania.

20 Aug 2010

Fenwal's new software release for Autopheresis-C system receives FDA 510(k) clearance

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system. Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors.

20 Aug 2010

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.

20 Aug 2010

Donor kidneys from deceased as good as those from brain-dead: Study

According to a new study from the UK, transplanted kidneys from patients whose hearts have stopped perform just as well as those from patients who are brain-dead but still alive. The former have been earlier considered to be weaker since the heart had stopped pumping blood into them before transplant. The study was published online by the The Lancet.

20 Aug 2010

New ways to tackle diabetes

According to a new analysis from UK, a diet rich in green leafy vegetables may reduce the risk of developing diabetes. The inference was drawn from six studies which looked into fruit and vegetable intake and found that only food including spinach and cabbage was found to have a significant positive effect. The findings were published in the British Medical Journal (BMJ).

19 Aug 2010

LIJ Medical Center achieves zero central-line infection rate in SICU

For one year and counting, Long Island Jewish Medical Center has achieved a zero central-line infection rate in its surgical intensive care unit, a significant accomplishment for hospitals.

19 Aug 2010

Emunamedica licenses technology for near-infrared wound monitor from Drexel University

Patients with diabetes-associated wounds could receive faster and more effective treatment thanks to a non-invasive device that monitors wound healing and is one step closer to market. Emunamedica LLC, a Florida-based healthcare start-up, has licensed technology for a near-infrared wound monitor from Drexel University. The device was developed by Dr. Elisabeth Papazoglou and Dr. Leonid Zubkov of Drexel's School of Biomedical Engineering, Science and Health Systems in collaboration with Dr. Michael S. Weingarten, M.D. of Drexel College of Medicine and their teams.

19 Aug 2010

Celera Corporation releases review article on KIF6 gene variant for CHD

Celera Corporation today announced the publication of a review article on the KIF6 gene variant as a predictor of risk of coronary heart disease (CHD) and reduction of CHD events from statin therapy.

19 Aug 2010

Research reveals possibility to convert one stem type to another without genetic modification

Scientists have reprogrammed stem cells from a key organ in the immune system in a development that could have implications for tissue regeneration.

19 Aug 2010

Assessment of critical illness during Emergency Medical Services care

A prediction score that included such factors as age, blood pressure, heart and respiratory rate for patients who received out-of-hospital emergency care was associated with the development of critical illness during hospitalization such as severe sepsis, the need for mechanical ventilation or death, according to a study in the August 18 issue of JAMA.

19 Aug 2010

Weight gain risk to develop endothelial cell dysfunction: Research

Mayo Clinic researchers found that healthy young people who put on as little as 9 pounds of fat, specifically in the abdomen, are at risk for developing endothelial cell dysfunction. Endothelial cells line the blood vessels and control the ability of the vessels to expand and contract.

19 Aug 2010

Hematopoietic cell transplantation survivors report of chronic health condition after procedure

Although hematopoietic cell transplantation (HCT) cures many blood diseases, two-thirds of long-term survivors report at least one chronic health condition after the procedure, according to a recent study published online in Blood, the journal of the American Society of Hematology.

19 Aug 2010

Policy restrictions for certain medications lead to decreased drug use and substantial savings for insurers

Policies that restrict reimbursement for certain medications can save money for health insurers without driving patients to seek other kinds of health care, a new review of studies suggests.

19 Aug 2010

EHSI signs option with Regenevita for 'Neo Natal Progenitor Cell Expansion Technology'

Emerging Healthcare Solutions, Inc. announced today that the Company has signed an option with Regenevita, owner of the right to license Neo Natal Progenitor Cell Expansion Technology in Latin America. The core technology on which the Regenevita technology is based was originally developed by NASA, the National Aeronautics and Space Administration, and was sub-licensed to Regenevita for use with Neo Natal Progenitor Cell Expansion.

19 Aug 2010

Unavoidable breakdowns in brain connections as we age: Study

It's unavoidable: breakdowns in brain connections slow down our physical response times as we age, a new study suggests.

19 Aug 2010

University of Maryland researchers link 3-D CT scans to standard ablation techniques

Researchers at the University of Maryland School of Medicine in Baltimore have developed a novel 3-D imaging approach that may improve the accuracy of treatment for ventricular tachycardia, a potentially life-threatening heart rhythm disorder that causes the heart to beat too fast. The new approach couples CT images with conventional ablation techniques to eliminate erratic electrical circuits in the heart that produce arrhythmias.

19 Aug 2010

New study sheds light on recovery from intoxication

A new study shows the impact of alcohol intoxication on reasoning and problem-solving abilities and may explain why some people feel they have recovered enough to drive after drinking. The research, led by Peter J. Snyder, PhD, vice president of research for Lifespan, is the first to explore how these cognitive abilities are impacted during both rising and declining blood alcohol concentrations, at matched blood alcohol level concentrations, and how self-evaluation of recovery differs from actual recovery from impairment.

19 Aug 2010

Bolder BioTechnology receives $600,000 NIH SBIR grant to study long-acting IL-11 analog in ARS

Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog to accelerate platelet recovery and improve survival in a mouse model of Acute Radiation Syndrome (ARS).

18 Aug 2010

70% rise in kidney disease in Australia over past 7 years: Report

According to a report released today by the Australian Institute of Health and Welfare (AIHW), with the rise of type II diabetes patients, there is increasing number of hospitalizations related to chronic kidney disease in Australia.

18 Aug 2010

Rush University Medical Center tests new drug therapy for West Nile fever

Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II clinical trial called PARADIGM.

18 Aug 2010

Blood News and Research

Study reports uneven decline of colorectal cancer mortality rate

Fenwal's new software release for Autopheresis-C system receives FDA 510(k) clearance

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Donor kidneys from deceased as good as those from brain-dead: Study

New ways to tackle diabetes

LIJ Medical Center achieves zero central-line infection rate in SICU

Emunamedica licenses technology for near-infrared wound monitor from Drexel University

Celera Corporation releases review article on KIF6 gene variant for CHD

Research reveals possibility to convert one stem type to another without genetic modification

Assessment of critical illness during Emergency Medical Services care

Weight gain risk to develop endothelial cell dysfunction: Research

Hematopoietic cell transplantation survivors report of chronic health condition after procedure

Policy restrictions for certain medications lead to decreased drug use and substantial savings for insurers

EHSI signs option with Regenevita for 'Neo Natal Progenitor Cell Expansion Technology'

Unavoidable breakdowns in brain connections as we age: Study

University of Maryland researchers link 3-D CT scans to standard ablation techniques

New study sheds light on recovery from intoxication

Bolder BioTechnology receives $600,000 NIH SBIR grant to study long-acting IL-11 analog in ARS

70% rise in kidney disease in Australia over past 7 years: Report

Rush University Medical Center tests new drug therapy for West Nile fever

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News